Cantor Fitzgerald Reiterates Overweight Rating on ADMA Biologics (ADMA) Mar 4, 2025 09:13AM
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Dec 9, 2022 04:05PM
ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Dec 9, 2022 04:05PM
ADMA Biologics (ADMA) Prices Public Offering for $60 Million of Common Stock Dec 7, 2022 08:45AM
ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock Dec 7, 2022 08:45AM


Dec 7, 2022 08:45AM ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock
Dec 6, 2022 04:05PM ADMA Biologics Announces Proposed Public Offering of Common Stock
Dec 6, 2022 04:05PM ADMA Biologics Announces Proposed Public Offering of Common Stock
Oct 25, 2021 04:01PM ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 25, 2021 04:01PM ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 21, 2021 09:01AM ADMA Biologics (ADMA) Announces Proposed $50M Stock Offering at $1/sh
Oct 21, 2021 09:00AM ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock
Oct 21, 2021 09:00AM ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock
Oct 20, 2021 04:02PM ADMA Biologics (ADMA) Announces Proposed Public Offering of Common Stock
Oct 20, 2021 04:01PM ADMA Biologics Announces Proposed Public Offering of Common Stock
Oct 20, 2021 04:01PM ADMA Biologics Announces Proposed Public Offering of Common Stock